Pivotal bioVenture Partners Investment Advisor LLC: ARQT position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Pivotal bioVenture Partners Investment Advisor LLC on ARQT, newest first. How the timeline and the estimate are built.
Pivotal bioVenture Partners Investment Advisor LLC held 1,265,283 ARQT shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 1,265,283 sharesChange vs previous 13F -90,609 shares
10.78% of the 13F portfolio, value $33,175,720.
13F-HR 0001012975-26-000759 filed by Pivotal bioVenture Partners Investment Advisor LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,355,892 sharesChange vs previous 13F -10,732 shares
11.42% of the 13F portfolio, value $31,944,816.
13F-HR 0001012975-26-000421 filed by Pivotal bioVenture Partners Investment Advisor LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,366,624 sharesChange vs previous 13F -753,884 shares
15.34% of the 13F portfolio, value $39,686,761.
13F-HR 0001012975-26-000133 filed by Pivotal bioVenture Partners Investment Advisor LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 2,120,508 sharesChange vs previous 13F 0 shares
23.11% of the 13F portfolio, value $39,971,576.
13F-HR 0001012975-25-000748 filed by Pivotal bioVenture Partners Investment Advisor LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,120,508 sharesChange vs previous 13F 0 shares
18.43% of the 13F portfolio, value $29,729,522.
13F-HR 0001012975-25-000438 filed by Pivotal bioVenture Partners Investment Advisor LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 2,120,508 sharesChange vs previous 13F 0 shares
26.84% of the 13F portfolio, value $33,164,745.
13F-HR 0001012975-25-000233 filed by Pivotal bioVenture Partners Investment Advisor LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 2,120,508 sharesChange vs previous 13F 0 shares
19.95% of the 13F portfolio, value $29,538,676.
13F-HR 0001012975-25-000081 filed by Pivotal bioVenture Partners Investment Advisor LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 2,120,508 sharesChange vs previous 13F not available
11.71% of the 13F portfolio, value $19,720,725.
13F-HR 0001012975-24-000471 filed by Pivotal bioVenture Partners Investment Advisor LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).